Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00311480
Status:
COMPLETED
Last Update Posted:
2007-03-13
First Post:
2006-04-04
Brief Title:
Safety and Immunogenicity of Two Doses Administered Three Weeks Apart of TwoSurface Antigen Adjuvanted With MF59C1 Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
Sponsor:
Organization:
Novartis